News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
844,372 Results
Type
Article (86456)
Company Profile (651)
Press Release (757264)
Multimedia
Podcasts (145)
Webinars (19)
Section
Business (232361)
Career Advice (4130)
Deals (39755)
Drug Delivery (126)
Drug Development (90900)
Employer Resources (198)
FDA (18079)
Job Trends (17355)
News (395916)
Policy (39732)
Tag
Academia (2993)
Academic (1)
Accelerated approval (10)
Adcomms (28)
Allergies (89)
Alliances (56788)
ALS (95)
Alzheimer's disease (1529)
Antibody-drug conjugate (ADC) (171)
Approvals (18039)
Artificial intelligence (284)
Autoimmune disease (35)
Automation (14)
Bankruptcy (402)
Best Places to Work (12511)
BIOSECURE Act (22)
Biosimilars (135)
Biotechnology (447)
Bladder cancer (89)
Brain cancer (31)
Breast cancer (306)
Cancer (2573)
Cardiovascular disease (169)
Career advice (3538)
Career pathing (34)
CAR-T (195)
CDC (25)
Cell therapy (523)
Cervical cancer (19)
Clinical research (73625)
Collaboration (965)
Company closure (3)
Compensation (583)
Complete response letters (30)
COVID-19 (2860)
CRISPR (60)
C-suite (296)
Cystic fibrosis (111)
Data (2585)
Decentralized trials (2)
Denatured (51)
Depression (56)
Diabetes (236)
Diagnostics (6799)
Digital health (10)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (135)
Drug pricing (116)
Drug shortages (19)
Duchenne muscular dystrophy (107)
Earnings (96062)
Editorial (41)
Employer branding (25)
Employer resources (169)
Events (129802)
Executive appointments (728)
FDA (19329)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (804)
Gene editing (125)
Generative AI (25)
Gene therapy (388)
GLP-1 (790)
Government (5182)
Grass and pollen (4)
Guidances (133)
Healthcare (20760)
Huntington's disease (32)
IgA nephropathy (41)
Immunology and inflammation (163)
Immuno-oncology (10)
Indications (32)
Infectious disease (3001)
Inflammatory bowel disease (161)
Inflation Reduction Act (13)
Influenza (53)
Intellectual property (102)
Interviews (813)
IPO (17765)
IRA (42)
Job creations (5191)
Job search strategy (2863)
Kidney cancer (14)
Labor market (55)
Layoffs (573)
Leadership (24)
Legal (10071)
Liver cancer (76)
Lung cancer (369)
Lymphoma (187)
Machine learning (9)
Management (65)
Manufacturing (359)
MASH (94)
Medical device (14330)
Medtech (14335)
Mergers & acquisitions (22392)
Metabolic disorders (723)
Multiple sclerosis (93)
NASH (22)
Neurodegenerative disease (126)
Neuropsychiatric disorders (27)
Neuroscience (2154)
NextGen: Class of 2025 (7671)
Non-profit (5063)
Now hiring (47)
Obesity (372)
Opinion (284)
Ovarian cancer (92)
Pain (84)
Pancreatic cancer (94)
Parkinson's disease (168)
Partnered (20)
Patents (239)
Patient recruitment (135)
Peanut (51)
People (65269)
Pharmaceutical (131)
Pharmacy benefit managers (16)
Phase I (22775)
Phase II (32039)
Phase III (24020)
Pipeline (1407)
Policy (204)
Postmarket research (3542)
Preclinical (10280)
Press Release (72)
Prostate cancer (117)
Psychedelics (40)
Radiopharmaceuticals (258)
Rare diseases (446)
Real estate (7391)
Recruiting (76)
Regulatory (26735)
Reports (57)
Research institute (2651)
Resumes & cover letters (650)
Rett syndrome (6)
RNA editing (10)
RSV (41)
Schizophrenia (86)
Series A (151)
Series B (98)
Service/supplier (25)
Sickle cell disease (55)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (36)
Startups (4296)
State (2)
Stomach cancer (12)
Supply chain (53)
Tariffs (52)
The Weekly (92)
Vaccines (816)
Venture capital (54)
Weight loss (242)
Women's health (44)
Worklife (20)
Date
Today (26)
Last 7 days (324)
Last 30 days (1481)
Last 365 days (25781)
2025 (14000)
2024 (34050)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1267)
Alabama (63)
Alaska (6)
Arizona (255)
Arkansas (8)
Asia (50201)
Australia (8841)
California (6510)
Canada (1827)
China (648)
Colorado (203)
Connecticut (256)
Delaware (170)
Europe (114875)
Florida (837)
Georgia (183)
Hawaii (2)
Idaho (64)
Illinois (516)
India (26)
Indiana (314)
Iowa (16)
Japan (187)
Kansas (115)
Kentucky (19)
Louisiana (10)
Maine (58)
Maryland (947)
Massachusetts (5063)
Michigan (197)
Minnesota (341)
Mississippi (2)
Missouri (59)
Montana (25)
Nebraska (26)
Nevada (67)
New Hampshire (52)
New Jersey (1816)
New Mexico (27)
New York (1830)
North Carolina (1105)
North Dakota (9)
Northern California (2881)
Ohio (192)
Oklahoma (14)
Oregon (45)
Pennsylvania (1319)
Puerto Rico (17)
Rhode Island (27)
South America (1650)
South Carolina (8)
South Dakota (1)
Southern California (2429)
Tennessee (40)
Texas (871)
United States (23787)
Utah (142)
Virginia (128)
Washington D.C. (47)
Washington State (589)
West Virginia (2)
Wisconsin (48)
844,372 Results for "remynd bio incubator wetenschapspark".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Unlearn and remynd Partner on Alzheimer’s Study to Strengthen Confidence in Early Clinical Signals Using Digital Twins
April 3, 2025
·
2 min read
Collaboration
Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off
At a satellite kickoff event to the annual BIO meeting, investment bankers and VCs gave reasons for optimism amid a ‘volatile’ period for the industry.
June 16, 2025
·
2 min read
·
Jef Akst
Press Releases
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
May 5, 2025
·
5 min read
Sponsored
Taipei City Government Partners With Six Biotech Companies to Showcase at BIO International Convention 2025
The 2025 BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S. time) at the Boston Convention & Exhibition Center. This year, Taipei City Government is partnering with six Taipei-based biotech companies, including PanCAD.ai Co., Ltd., Instant NanoBiosensors Co., Ltd., Bened Biomedical Co., Ltd., Cancer Free Biotech Ltd., Xantho Biotechnology Co., Ltd., and Energenesis Biomedical Co., Ltd., to showcase their innovations at the Taiwan Pavilion (Booth #1645) in the Taipei Exhibition Area.
June 16, 2025
·
5 min read
Podcast
FDA Churn Continues, RFK Faces Congress, Obesity Insights at ADA, BIO2025 Recap
Robert F. Kennedy Jr. testified in front of largely combative congresspeople on vaccine policy, his MAHA report and more; the mass leadership exodus at the FDA continues as CDER and CBER shed key staff; Kennedy’s revamped CDC vaccine advisors convene for their first meeting; Novo and Lilly present new data at the American Diabetes Association’s annual meeting; and BioSpace recaps BIO2025.
June 25, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
April 30, 2025
·
6 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
Business
More Than a One Trick Pony, Lilly Feeds Success Back Into Biotech
On the sidelines of BIO2025, Julie Gilmore, head of Lilly Gateway Labs, shares her thoughts on the $1.3 billion Verve Therapeutics buy, where Lilly’s therapeutic puck is potentially going and how the company is leveraging its unprecedented success in obesity to support young biotechs.
June 18, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Libertas Bio, a Formation Bio subsidiary, License of Gusacitinib, a Dual JAK/SYK Inhibitor, to Sanofi
June 23, 2025
·
2 min read
1 of 84,438
Next